The Leadership Team at RosVivo Therapeutics is responsible for guiding the company's strategic vision and operational execution in the development of innovative therapies targeting diseases through cutting-edge microRNA and siRNA technologies. Comprising the CEO, co-founders, and key scientific leaders, the team collaborates to oversee research initiatives, ensure regulatory compliance, secure funding, and drive the advancement of first-in-class drug and diagnostic test pipelines focusing on T2D, obesity, and COVID-19.